Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Cheong, Jae-Ho  [Clear All Filters]
2023
Jang E, Shin M-K, Kim H, Lim JYeon, Lee JEun, Park J, Kim J, Kim H, Shin Y, Son H-Y, et al. Clinical molecular subtyping reveals intrinsic mesenchymal reprogramming in gastric cancer cells. Exp Mol Med. 2023.
Sung J-Y, Cheong J-H. Gene signature related to cancer stem cells and fibroblasts of stem-like gastric cancer predicts immunotherapy response. Clin Transl Med. 2023;13(8):e1347.
Yoon BKyung, Kim H, Oh TGyu, Oh SKyu, Jo S, Kim MK, Chun K-H, Hwang N, Lee S, Jin S, et al. PHGDH preserves one-carbon cycle to confer metabolic plasticity in chemoresistant gastric cancer during nutrient stress. Proc Natl Acad Sci U S A. 2023;120(21):e2217826120.
Lee YSun, Kim HSun, Kim HJung, Kang HWoong, Lee DEun, Kim MJin, Hong WChris, Kim JHyun, Kim M, Cheong J-H, et al. The role of LOXL2 induced by glucose metabolism-activated NF-κB in maintaining drug resistance through EMT and cancer stemness in gemcitabine-resistant PDAC. J Mol Med (Berl). 2023.
2022
Lee SHwan, Jeong YSeong, Lee S, Sohn BHwa, Hwang HKyoung, Choi GHong, Kang CMoo, Choi JSub, Lee WJung, Cheong J-H, et al. Two distinct stem cell-like subtypes of hepatocellular carcinoma with clinical significance and their therapeutic potentials. Cancer Commun (Lond). 2022.
2020
Choi H-J, Jhe Y-L, Kim J, Lim JYeon, Lee JEun, Shin M-K, Cheong J-H. FoxM1-dependent and fatty acid oxidation-mediated ROS modulation is a cell-intrinsic drug resistance mechanism in cancer stem-like cells. Redox Biol. 2020;36:101589.
2019
Shin M-K, Cheong J-H. Mitochondria-centric bioenergetic characteristics in cancer stem-like cells. Arch Pharm Res. 2019.
2015
Jang H, Yang J, Lee E, Cheong J-H. Metabolism in embryonic and cancer stemness. Arch Pharm Res. 2015.